Welch Allyn announces European restructuring initiatives

Medical Company Restructures

Welch Allyn has announced details of the planned reorganisation of its European business, as part of a wider global restructuring effort.

Under the new plans, the medical technology firm will establish a new Europe/Middle East headquarters and operations centre in the Netherlands, while transferring its manufacturing activity in Germany to its existing Mexico site.

The firm will continue to operate its Irish facility in Navan, moving some functions to the new HQ over the next two years and optimising other roles based on its corporate strategy and business conditions.

Welch Allyn originally announced its plans to reorganise its business structure in September 2012 and has produced these proposals for Europe following a rigorous 90-day evaluation.

Steve Meyer, president and chief executive officer at Welch Allyn, said: "We firmly believe that achieving the full potential of this restructuring program, including European realignment, will help position us for long-term success at each of our global facilities."

This comes after the firm announced the appointment of Joseph Hennigan as its new executive vice-president and chief financial officer last month.

See all the latest jobs in Medical Devices
Return to news